Lymphodepletion With Low Dose Total Body Irradiation Before Standard of Care Tisagenlecleucel for the Treatment of Relapsed and Recurrent Large B-cell Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Tisagenlecleucel
Related studies linked through entity extraction aliases.
Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Relapsed/Refractory Large B-cell Lymphoma With NT-I7 Post-CD19 CAR T-cell Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2